Targeting PI3Kd attenuates influenza virus-induced inflammation in a murine model of asthma exacerbation Source: International Congress 2017 – Infection and exacerbation science Year: 2017
Cellular approach of salbutamol effects on chronic lung inflammation induced by OVA in murine model Source: Eur Respir J 2004; 24: Suppl. 48, 127s Year: 2004
Decreased Smad7 expression in the airways of a mouse model of chronic asthma Source: Annual Congress 2004 - Animal models of allergic airway disease Year: 2004
Increased expression of Lipocalin2 suppresses allergen-induced airway disease in mice Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008
Activated protein C inhibits bronchial inflammation and hyperresponsiveness in a mouse model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 618s Year: 2002
Disruption of CD44 variant 6 abolished bronchial hyperresponsiveness, inflammation and mast cell myositis in a murine model of asthma Source: Eur Respir J 2006; 28: Suppl. 50, 217s Year: 2006
ST2 gene knockout attenuates allergic airways disease Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs Year: 2006
The histological effects of interleukin-10 on mouse lung inflammation after recombinant Sendai virus vector transduction Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence Year: 2007
MIF antagonism restores corticosteroid sensitivity in a murine model of severe asthma Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018
EP4 agonist increases myeloid derived suppressor cells activity and reduces airway inflammatory events in a murine model of asthma Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020
Intratumoral injection of plasmid-encoded flagellin inhibits growth of NSCLC-cells in murine lung cancer model Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012
Overexpression of eNOS suppresses asthmatic features in a mouse model of allergic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 28s Year: 2002
CpG oligodeoxynucleotide treatment prevents the development of airway remodelling in a murine model of chronic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 2s Year: 2002
Blocking IL-4Ra with dupilumab prevents lung inflammation in a mouse asthma model Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018
Influence of CpG-oligodeoxynucleotides and dexamethasone on remodeling and expression of MMP-9 in murine model of chronic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 224s Year: 2006
Characterisation of endogenous IL-33 using a model of Alternaria -induced pulmonary inflammation Source: Annual Congress 2012 - Cellular signalling mechanisms in the airways Year: 2012
Transgenic mice overexpressing IL-18 display increased IL-13 in the airways but no changes of the airway hyperresponsiveness in a murine model of late-phase asthma: evidence for a dual role of IL-18 on mucosal Th1/Th2 responses Source: Eur Respir J 2002; 20: Suppl. 38, 1s Year: 2002
Airway administration of therapeutic antibody (tAb) confers higher protection than parenteral administration in a murine model of acute lung infection Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies Year: 2018
In vivo blockade of CTLA-4 counteracts inhalation tolerance and leads to development of allergic airway inflammation in mice repeatedly exposed to aerosolized ovalbumin Source: Eur Respir J 2004; 24: Suppl. 48, 6s Year: 2004
Targeted adenoviral gene transfer of wild type (wt) BMPR2 attenuates hypoxic pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 238s Year: 2005